Chattanooga Kidney Center North, Llc in Chattanooga, Tennessee - Dialysis Center

Chattanooga Kidney Center North, Llc is a medicare approved dialysis facility center in Chattanooga, Tennessee and it has 28 dialysis stations. It is located in Hamilton county at 649 Morrison Springs Road, Chattanooga, TN, 37415. You can reach out to the office of Chattanooga Kidney Center North, Llc at (423) 468-1000. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. Chattanooga Kidney Center North, Llc has the following ownership type - Profit. It was first certified by medicare in November, 2008. The medicare id for this facility is 442679 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameChattanooga Kidney Center North, Llc
Location649 Morrison Springs Road, Chattanooga, Tennessee
No. of Dialysis Stations 28
Medicare ID442679
Managed ByIndependent
Ownership TypeProfit
Late Shifts No

Contact Information


649 Morrison Springs Road, Chattanooga, Tennessee, 37415
(423) 468-1000

News Archive

Nightingale revenue decreases 14% to $3.8 million for first quarter 2012

Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services, announces its financial results for the quarter ended June 30, 2011.

Researchers create artificial RNA inhibitor to block excess blood cells formation

Researchers at UT Southwestern Medical Center have uncovered a key step in the creation of new red blood cells in an animal study.They found that a tiny fragment of ribonucleic acid (RNA), a chemical cousin of DNA, prompts stem cells to mature into red blood cells. The researchers also created an artificial RNA inhibitor to block this process.

DaVita's nocturnal dialysis treatment allows patients to dialyze in-clinic while sleeping overnight

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced its nocturnal dialysis patient population has reached a milestone, with 1,000 patients having received this life-saving treatment in more than 90 DaVita(R) centers around the nation. DaVita has one of the largest nocturnal patient populations in the country.

High doses of steroids fail to improve outcomes in pediatric liver disease

A multi-center study concludes that treating infants with high doses of steroids fails to improve medical outcomes in the end-stage pediatric liver disease biliary atresia and leads to earlier onset of serious adverse events.

Read more Medical News

› Verified 1 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Chattanooga Kidney Center North, Llc from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1215190996
Doing Business AsChattanooga Kidney Centers Of North Llc
Address649 Morrison Springs Rd Chattanooga, Tennessee, 37405
Phone Number(423) 648-4900

News Archive

Nightingale revenue decreases 14% to $3.8 million for first quarter 2012

Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services, announces its financial results for the quarter ended June 30, 2011.

Researchers create artificial RNA inhibitor to block excess blood cells formation

Researchers at UT Southwestern Medical Center have uncovered a key step in the creation of new red blood cells in an animal study.They found that a tiny fragment of ribonucleic acid (RNA), a chemical cousin of DNA, prompts stem cells to mature into red blood cells. The researchers also created an artificial RNA inhibitor to block this process.

DaVita's nocturnal dialysis treatment allows patients to dialyze in-clinic while sleeping overnight

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced its nocturnal dialysis patient population has reached a milestone, with 1,000 patients having received this life-saving treatment in more than 90 DaVita(R) centers around the nation. DaVita has one of the largest nocturnal patient populations in the country.

High doses of steroids fail to improve outcomes in pediatric liver disease

A multi-center study concludes that treating infants with high doses of steroids fails to improve medical outcomes in the end-stage pediatric liver disease biliary atresia and leads to earlier onset of serious adverse events.

Read more Medical News

› Verified 1 days ago


Survey of Patient's Experiences

Nephrologists Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that nephrologists always communicated and cared for them.67%67%
Patients who reported that nephrologists usually communicated and cared for them.16%15%
Patients who reported that nephrologists sometimes or never communicated and cared for them.17%18%
Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).50%60%
Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).40%26%
Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).10%14%

News Archive

Nightingale revenue decreases 14% to $3.8 million for first quarter 2012

Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services, announces its financial results for the quarter ended June 30, 2011.

Researchers create artificial RNA inhibitor to block excess blood cells formation

Researchers at UT Southwestern Medical Center have uncovered a key step in the creation of new red blood cells in an animal study.They found that a tiny fragment of ribonucleic acid (RNA), a chemical cousin of DNA, prompts stem cells to mature into red blood cells. The researchers also created an artificial RNA inhibitor to block this process.

DaVita's nocturnal dialysis treatment allows patients to dialyze in-clinic while sleeping overnight

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced its nocturnal dialysis patient population has reached a milestone, with 1,000 patients having received this life-saving treatment in more than 90 DaVita(R) centers around the nation. DaVita has one of the largest nocturnal patient populations in the country.

High doses of steroids fail to improve outcomes in pediatric liver disease

A multi-center study concludes that treating infants with high doses of steroids fails to improve medical outcomes in the end-stage pediatric liver disease biliary atresia and leads to earlier onset of serious adverse events.

Read more Medical News

› Verified 1 days ago

Dialysis Center Staff Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible.75%62%
Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible.12%20%
Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free.13%18%
Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).80%62%
Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).17%26%
Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).3%12%

News Archive

Nightingale revenue decreases 14% to $3.8 million for first quarter 2012

Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services, announces its financial results for the quarter ended June 30, 2011.

Researchers create artificial RNA inhibitor to block excess blood cells formation

Researchers at UT Southwestern Medical Center have uncovered a key step in the creation of new red blood cells in an animal study.They found that a tiny fragment of ribonucleic acid (RNA), a chemical cousin of DNA, prompts stem cells to mature into red blood cells. The researchers also created an artificial RNA inhibitor to block this process.

DaVita's nocturnal dialysis treatment allows patients to dialyze in-clinic while sleeping overnight

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced its nocturnal dialysis patient population has reached a milestone, with 1,000 patients having received this life-saving treatment in more than 90 DaVita(R) centers around the nation. DaVita has one of the largest nocturnal patient populations in the country.

High doses of steroids fail to improve outcomes in pediatric liver disease

A multi-center study concludes that treating infants with high doses of steroids fails to improve medical outcomes in the end-stage pediatric liver disease biliary atresia and leads to earlier onset of serious adverse events.

Read more Medical News

› Verified 1 days ago

Overall Dialysis Center Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. 86%80%
Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them.14%20%
Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).79%68%
Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).17%20%
Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).4%12%

News Archive

Nightingale revenue decreases 14% to $3.8 million for first quarter 2012

Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services, announces its financial results for the quarter ended June 30, 2011.

Researchers create artificial RNA inhibitor to block excess blood cells formation

Researchers at UT Southwestern Medical Center have uncovered a key step in the creation of new red blood cells in an animal study.They found that a tiny fragment of ribonucleic acid (RNA), a chemical cousin of DNA, prompts stem cells to mature into red blood cells. The researchers also created an artificial RNA inhibitor to block this process.

DaVita's nocturnal dialysis treatment allows patients to dialyze in-clinic while sleeping overnight

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced its nocturnal dialysis patient population has reached a milestone, with 1,000 patients having received this life-saving treatment in more than 90 DaVita(R) centers around the nation. DaVita has one of the largest nocturnal patient populations in the country.

High doses of steroids fail to improve outcomes in pediatric liver disease

A multi-center study concludes that treating infants with high doses of steroids fails to improve medical outcomes in the end-stage pediatric liver disease biliary atresia and leads to earlier onset of serious adverse events.

Read more Medical News

› Verified 1 days ago

Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data58
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL7

News Archive

Nightingale revenue decreases 14% to $3.8 million for first quarter 2012

Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services, announces its financial results for the quarter ended June 30, 2011.

Researchers create artificial RNA inhibitor to block excess blood cells formation

Researchers at UT Southwestern Medical Center have uncovered a key step in the creation of new red blood cells in an animal study.They found that a tiny fragment of ribonucleic acid (RNA), a chemical cousin of DNA, prompts stem cells to mature into red blood cells. The researchers also created an artificial RNA inhibitor to block this process.

DaVita's nocturnal dialysis treatment allows patients to dialyze in-clinic while sleeping overnight

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced its nocturnal dialysis patient population has reached a milestone, with 1,000 patients having received this life-saving treatment in more than 90 DaVita(R) centers around the nation. DaVita has one of the largest nocturnal patient populations in the country.

High doses of steroids fail to improve outcomes in pediatric liver disease

A multi-center study concludes that treating infants with high doses of steroids fails to improve medical outcomes in the end-stage pediatric liver disease biliary atresia and leads to earlier onset of serious adverse events.

Read more Medical News

› Verified 1 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center93
    Adult patient months included in Kt/V greater than or equal to 1.2867
    Percentage of adult patients getting regular hemodialysis at the center97
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Nightingale revenue decreases 14% to $3.8 million for first quarter 2012

    Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services, announces its financial results for the quarter ended June 30, 2011.

    Researchers create artificial RNA inhibitor to block excess blood cells formation

    Researchers at UT Southwestern Medical Center have uncovered a key step in the creation of new red blood cells in an animal study.They found that a tiny fragment of ribonucleic acid (RNA), a chemical cousin of DNA, prompts stem cells to mature into red blood cells. The researchers also created an artificial RNA inhibitor to block this process.

    DaVita's nocturnal dialysis treatment allows patients to dialyze in-clinic while sleeping overnight

    DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced its nocturnal dialysis patient population has reached a milestone, with 1,000 patients having received this life-saving treatment in more than 90 DaVita(R) centers around the nation. DaVita has one of the largest nocturnal patient populations in the country.

    High doses of steroids fail to improve outcomes in pediatric liver disease

    A multi-center study concludes that treating infants with high doses of steroids fails to improve medical outcomes in the end-stage pediatric liver disease biliary atresia and leads to earlier onset of serious adverse events.

    Read more Medical News

    › Verified 1 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Chattanooga Kidney Center North, Llc with elevated calcium levels.

Patients with hypercalcemia93
Hypercalcemia patient months867
Patients with Serumphosphor102
Patients with Serumphosphor less than 3.5 mg/dL4
Patients with Serumphosphor from 3.5 to 4.5 mg/dL27
Patients with Serumphosphor from 4.6 to 5.5 mg/dL39
Patients with Serumphosphor from 5.6 to 7 mg/dL20
Patients with Serumphosphor greater than 7 mg/dL10

News Archive

Nightingale revenue decreases 14% to $3.8 million for first quarter 2012

Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services, announces its financial results for the quarter ended June 30, 2011.

Researchers create artificial RNA inhibitor to block excess blood cells formation

Researchers at UT Southwestern Medical Center have uncovered a key step in the creation of new red blood cells in an animal study.They found that a tiny fragment of ribonucleic acid (RNA), a chemical cousin of DNA, prompts stem cells to mature into red blood cells. The researchers also created an artificial RNA inhibitor to block this process.

DaVita's nocturnal dialysis treatment allows patients to dialyze in-clinic while sleeping overnight

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced its nocturnal dialysis patient population has reached a milestone, with 1,000 patients having received this life-saving treatment in more than 90 DaVita(R) centers around the nation. DaVita has one of the largest nocturnal patient populations in the country.

High doses of steroids fail to improve outcomes in pediatric liver disease

A multi-center study concludes that treating infants with high doses of steroids fails to improve medical outcomes in the end-stage pediatric liver disease biliary atresia and leads to earlier onset of serious adverse events.

Read more Medical News

› Verified 1 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 75
Patient months included in arterial venous fistula and catheter summaries 682
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment64
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer18

News Archive

Nightingale revenue decreases 14% to $3.8 million for first quarter 2012

Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services, announces its financial results for the quarter ended June 30, 2011.

Researchers create artificial RNA inhibitor to block excess blood cells formation

Researchers at UT Southwestern Medical Center have uncovered a key step in the creation of new red blood cells in an animal study.They found that a tiny fragment of ribonucleic acid (RNA), a chemical cousin of DNA, prompts stem cells to mature into red blood cells. The researchers also created an artificial RNA inhibitor to block this process.

DaVita's nocturnal dialysis treatment allows patients to dialyze in-clinic while sleeping overnight

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced its nocturnal dialysis patient population has reached a milestone, with 1,000 patients having received this life-saving treatment in more than 90 DaVita(R) centers around the nation. DaVita has one of the largest nocturnal patient populations in the country.

High doses of steroids fail to improve outcomes in pediatric liver disease

A multi-center study concludes that treating infants with high doses of steroids fails to improve medical outcomes in the end-stage pediatric liver disease biliary atresia and leads to earlier onset of serious adverse events.

Read more Medical News

› Verified 1 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary89
Hospitalization Rate in facility153.2 (As Expected)
Hospitalization Rate: Upper Confidence Limit258.7
Hospitalization Rate: Lower Confidence Limit93.3

News Archive

Nightingale revenue decreases 14% to $3.8 million for first quarter 2012

Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services, announces its financial results for the quarter ended June 30, 2011.

Researchers create artificial RNA inhibitor to block excess blood cells formation

Researchers at UT Southwestern Medical Center have uncovered a key step in the creation of new red blood cells in an animal study.They found that a tiny fragment of ribonucleic acid (RNA), a chemical cousin of DNA, prompts stem cells to mature into red blood cells. The researchers also created an artificial RNA inhibitor to block this process.

DaVita's nocturnal dialysis treatment allows patients to dialyze in-clinic while sleeping overnight

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced its nocturnal dialysis patient population has reached a milestone, with 1,000 patients having received this life-saving treatment in more than 90 DaVita(R) centers around the nation. DaVita has one of the largest nocturnal patient populations in the country.

High doses of steroids fail to improve outcomes in pediatric liver disease

A multi-center study concludes that treating infants with high doses of steroids fails to improve medical outcomes in the end-stage pediatric liver disease biliary atresia and leads to earlier onset of serious adverse events.

Read more Medical News

› Verified 1 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Chattanooga Kidney Center North, Llc were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility15.3 (As Expected)
Readmission Rate: Upper Confidence Limit25.1
Readmission Rate: Lower Confidence Limit8.4

News Archive

Nightingale revenue decreases 14% to $3.8 million for first quarter 2012

Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services, announces its financial results for the quarter ended June 30, 2011.

Researchers create artificial RNA inhibitor to block excess blood cells formation

Researchers at UT Southwestern Medical Center have uncovered a key step in the creation of new red blood cells in an animal study.They found that a tiny fragment of ribonucleic acid (RNA), a chemical cousin of DNA, prompts stem cells to mature into red blood cells. The researchers also created an artificial RNA inhibitor to block this process.

DaVita's nocturnal dialysis treatment allows patients to dialyze in-clinic while sleeping overnight

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced its nocturnal dialysis patient population has reached a milestone, with 1,000 patients having received this life-saving treatment in more than 90 DaVita(R) centers around the nation. DaVita has one of the largest nocturnal patient populations in the country.

High doses of steroids fail to improve outcomes in pediatric liver disease

A multi-center study concludes that treating infants with high doses of steroids fails to improve medical outcomes in the end-stage pediatric liver disease biliary atresia and leads to earlier onset of serious adverse events.

Read more Medical News

› Verified 1 days ago

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Chattanooga Kidney Center North, Llc get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
Infection Rate in facility.25 (Better than Expected)
SIR: Upper Confidence Limit.84
SIR: Lower Confidence Limit.04

News Archive

Nightingale revenue decreases 14% to $3.8 million for first quarter 2012

Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services, announces its financial results for the quarter ended June 30, 2011.

Researchers create artificial RNA inhibitor to block excess blood cells formation

Researchers at UT Southwestern Medical Center have uncovered a key step in the creation of new red blood cells in an animal study.They found that a tiny fragment of ribonucleic acid (RNA), a chemical cousin of DNA, prompts stem cells to mature into red blood cells. The researchers also created an artificial RNA inhibitor to block this process.

DaVita's nocturnal dialysis treatment allows patients to dialyze in-clinic while sleeping overnight

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced its nocturnal dialysis patient population has reached a milestone, with 1,000 patients having received this life-saving treatment in more than 90 DaVita(R) centers around the nation. DaVita has one of the largest nocturnal patient populations in the country.

High doses of steroids fail to improve outcomes in pediatric liver disease

A multi-center study concludes that treating infants with high doses of steroids fails to improve medical outcomes in the end-stage pediatric liver disease biliary atresia and leads to earlier onset of serious adverse events.

Read more Medical News

› Verified 1 days ago

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Chattanooga Kidney Center North, Llc's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 82
Transfusion Rate in facility34.8 (As Expected)
Transfusion Rate: Upper Confidence Limit80
Transfusion Rate: Lower Confidence Limit16.8

News Archive

Nightingale revenue decreases 14% to $3.8 million for first quarter 2012

Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services, announces its financial results for the quarter ended June 30, 2011.

Researchers create artificial RNA inhibitor to block excess blood cells formation

Researchers at UT Southwestern Medical Center have uncovered a key step in the creation of new red blood cells in an animal study.They found that a tiny fragment of ribonucleic acid (RNA), a chemical cousin of DNA, prompts stem cells to mature into red blood cells. The researchers also created an artificial RNA inhibitor to block this process.

DaVita's nocturnal dialysis treatment allows patients to dialyze in-clinic while sleeping overnight

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced its nocturnal dialysis patient population has reached a milestone, with 1,000 patients having received this life-saving treatment in more than 90 DaVita(R) centers around the nation. DaVita has one of the largest nocturnal patient populations in the country.

High doses of steroids fail to improve outcomes in pediatric liver disease

A multi-center study concludes that treating infants with high doses of steroids fails to improve medical outcomes in the end-stage pediatric liver disease biliary atresia and leads to earlier onset of serious adverse events.

Read more Medical News

› Verified 1 days ago

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at Chattanooga Kidney Center North, Llc lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary427
Mortality Rate in facility15.5 (As Expected)
Mortality Rate: Upper Confidence Limit20.1
Mortality Rate: Lower Confidence Limit11.6

News Archive

Nightingale revenue decreases 14% to $3.8 million for first quarter 2012

Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services, announces its financial results for the quarter ended June 30, 2011.

Researchers create artificial RNA inhibitor to block excess blood cells formation

Researchers at UT Southwestern Medical Center have uncovered a key step in the creation of new red blood cells in an animal study.They found that a tiny fragment of ribonucleic acid (RNA), a chemical cousin of DNA, prompts stem cells to mature into red blood cells. The researchers also created an artificial RNA inhibitor to block this process.

DaVita's nocturnal dialysis treatment allows patients to dialyze in-clinic while sleeping overnight

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced its nocturnal dialysis patient population has reached a milestone, with 1,000 patients having received this life-saving treatment in more than 90 DaVita(R) centers around the nation. DaVita has one of the largest nocturnal patient populations in the country.

High doses of steroids fail to improve outcomes in pediatric liver disease

A multi-center study concludes that treating infants with high doses of steroids fails to improve medical outcomes in the end-stage pediatric liver disease biliary atresia and leads to earlier onset of serious adverse events.

Read more Medical News

› Verified 1 days ago


Dialysis Facility in Chattanooga, TN

DCI Chattanooga 3rd St
Location: 1425 East Third Street, Chattanooga, Tennessee, 37404
Phone: (423) 698-0927
DCI Chattanooga Broad St
Location: 3555 Broad St., Chattanooga, Tennessee, 37409
Phone: (423) 756-8808
DCI Lyerly
Location: 2300 East Third Street, Chattanooga, Tennessee, 37404
Phone: (423) 698-6422
Chattanooga Kidney Center
Location: 2118 Stein Drive, Chattanooga, Tennessee, 37421
Phone: (423) 648-4900
Chattanooga Kidney Center North, Llc
Location: 649 Morrison Springs Road, Chattanooga, Tennessee, 37415
Phone: (423) 468-1000

News Archive

Nightingale revenue decreases 14% to $3.8 million for first quarter 2012

Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services, announces its financial results for the quarter ended June 30, 2011.

Researchers create artificial RNA inhibitor to block excess blood cells formation

Researchers at UT Southwestern Medical Center have uncovered a key step in the creation of new red blood cells in an animal study.They found that a tiny fragment of ribonucleic acid (RNA), a chemical cousin of DNA, prompts stem cells to mature into red blood cells. The researchers also created an artificial RNA inhibitor to block this process.

DaVita's nocturnal dialysis treatment allows patients to dialyze in-clinic while sleeping overnight

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced its nocturnal dialysis patient population has reached a milestone, with 1,000 patients having received this life-saving treatment in more than 90 DaVita(R) centers around the nation. DaVita has one of the largest nocturnal patient populations in the country.

High doses of steroids fail to improve outcomes in pediatric liver disease

A multi-center study concludes that treating infants with high doses of steroids fails to improve medical outcomes in the end-stage pediatric liver disease biliary atresia and leads to earlier onset of serious adverse events.

Read more Medical News

› Verified 1 days ago


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.